An initial strategy of 1-year romosozumab followed by alendronate is superior over alendronate alone in reducing new vertebral fractures in postmenopausal women with osteoporosis at high risk for fracture, according to the ARCH* study.
Even small risk reductions achieved with improved air quality afford health benefits similar to that gained with smoking and systolic hypertension control, according to a study in an urban China population.
A real-world study conducted by the Chinese University of Hong Kong (CUHK) showed that attainment of LDL-cholesterol (LDL-C) goal of less than 2.6 mmol/L is sufficient to significantly reduce mortality among Chinese patients who have undergone percutaneous coronary intervention (PCI).
Using bioabsorbable polymer drug-eluting stents (DES) with a shorter duration of double antiplatelet therapy (DAPT) in elderly patients undergoing percutaneous coronary intervention (PCI) leads to fewer adverse events than bare-metal stents (BMS) without increasing bleeding risk, according to the SENIOR* trial presented at TCT 2017 Congress.
A recent study has shown that despite a publication bias that could have led to an overestimation of mortality, eosinophilic myocarditis (EM) has a poor prognosis during the acute phase, and the associated conditions are identified in about 65 percent of cases.
Malfunctions in left ventricular assist devices (LVADs) appear to be much more comprehensive than pump failure alone, occurring in different components at different rates based on the type of LVAD, a study has shown.
While electrocardiogram (EKG) provides an earlier and more accurate neonatal heart rate than a pulse oximeter, there is not enough evidence to conclude that clinical interventions can be initiated significantly earlier, a recent study shows.
Red yeast rice extracts have been used in traditional medicine for centuries.1 In recent times, an extract from red yeast rice, Xuezhikang® (XZK), has been studied for its role in dyslipidaemia and cardiovascular disease. This review will look at some of the clinical trials that have done so.
Enriching salt with both potassium and magnesium in the long term may provide additional benefits for stroke patient recovery from neurologic deficits, suggests a recent study involving Taiwanese patients.